1 Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, and evaluation.

2 Light-controllable systems based on TiO-ZIF-8 composites for targeted drug release: communicating with tumour cells.

3 Ultrasensitive photoelectrochemical microRNA biosensor based on doxorubicin sensitized graphitic carbon nitride assisted by a target-activated enzyme-free DNA walker.

4 SHORT COMMUNICATION-Anticancer activity of Ziziphus mauritiana roots against human breast cancer cell line.

5 The synergistic cytotoxic effects of doxorubicin and extract on human breast cancer cell line T47-D.

6 Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.

7 Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.

8 Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.

9 Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.

10 Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

11 Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study.

12 mechanisms of antibiotic resistance

13 novel polymyxin combination with antineoplastic mitotane improved the bacterial killing against polymyxin-resistant multidrug-resistant gram-negative pathogens

14 pharmacological modulation of anti-tumor immunity induced by oncolytic viruses

15 emerging therapies for childhood polycystic kidney disease

16 a new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

17 a better antiviral efficacy found in nucleos(t)ide analog (na) combinations with interferon therapy than na monotherapy for hbeag positive chronic hepatitis b: a meta-analysis

18 synergistic effect of haloduracin and chloramphenicol against clinically important gram-positive bacteria

19 self-assembled albumin nanoparticles for combination therapy in prostate cancer

20 Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy

21 Dual drug delivery system of RAPTA-C and paclitaxel based on fructose coated nanoparticles for metastatic cancer treatment.

22 Drug independence and the curability of cancer by combination chemotherapy.

23 Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges.

24 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

25 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

26 Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

27 In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

28 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

29 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

30 Current perspectives on combination therapy in the management of hypertension

31 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

32 Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy

33 Azilsartan/chlorthalidone combination therapy for blood pressure control

34 Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

35 Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility

36 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

37 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

38 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

39 Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

40 In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

41 Successful Treatment of Sjögren’s Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid

42 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

43 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

44 Current perspectives on combination therapy in the management of hypertension

45 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

46 Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy

47 Azilsartan/chlorthalidone combination therapy for blood pressure control

48 Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

49 Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility

50 Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

51 Artemisinin-based combination therapy: knowledge and perceptions of patent medicine dealers in Owerri Metropolis, Imo State, Nigeria and implications for compliance with current malaria treatment protocol.

52 Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: An open-label, randomized, controlled study

53 Photodynamic therapy using zinc phthalocyanine in low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.

54 Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.

55 Self-assembled albumin nanoparticles for combination therapy in prostate cancer

56 The effectiveness of combination therapy with 308-nm excimer laser in vitiligo in Han Chinese People.

57 Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients.

58 The efficacy of 308 nm UV excimer light as monotherapy and combination therapy with topical khellin 4% and/or tacrolimus 0.1% in the treatment of vitiligo

59 A successful helium-neon laser and topical tacrolimus combination therapy in one child with vitiligo

60 The effectiveness of excimer laser on vitiligo treatment in comparison with a combination therapy of Excimer laser and tacrolimus in an Iranian population

61 Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: A proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment

62 Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania

63 Exclusive plaque psoriasis of the lips: efficacy of combination therapy of topical tacrolimus, calcipotriol, and betamethasone dipropionate.

64 Synthesis of doxorubicin and miRNA stimuli-sensitive conjugates for combination therapy

65 Uniformly sized hollow microspheres loaded with polydopamine nanoparticles and doxorubicin for local chemo-photothermal combination therapy

66 Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy

67 Efficacy and safety of sorafenib-gemcitabine combination therapy in advanced hepatocellular carcinoma: an open-label Phase II feasibility study.

68 Incretin combination therapy for the treatment of non-alcoholic steatohepatitis.

69 Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy.

70 Combination Therapy and Opioids: Effectiveness of Transcranial Direct-Current Stimulation (tDCS) and Emotion Regulation Training in Reducing Current Drug Craving.

71 Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes

72 Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients: A Randomized Controlled Comparison With Zidovudine Monotherapy

73 Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

74 Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

75 Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

76 Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

77 Effective Combination Therapy Using Interferon-γ and Interleukin-2 for Disseminated Mycobacterium avium Complex Infection in a Pediatric Patient with AIDS

78 Switch from Ritonavir to Indinavir in Combination Therapy for HIV-1—Infected Children

79 Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

80 Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

81 Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

82 Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

83 sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus

84 step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy

85 partial cranial cruciate ligament tears treated with stem cell and platelet rich plasma combination therapy in 36 dogs: a retrospective study

86 inhibition of immune checkpoints and vascular endothelial growth factor as combination therapy for cancer: an overview of rationale, preclinical evidence, and initial clinical data

87 pulmonary sarcoidosis activation following neoadjuvant pembrolizumab plus chemotherapy combination therapy in a patient with non-small cell lung cancer: a case report

88 ace inhibitors &ndash; angiotensin ii receptor antagonists: a useful combination therapy for ischemic heart disease

89 outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination

90 long-lasting effects of anti-vegf/photodynamic combination therapy in the treatment of exudative age-related macular degeneration: a retrospective chart review

91 adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria: a systematic review and meta-analysis

92 carfilzomib boosted combination therapy for relapsed multiple myeloma

93 etanercept plus methotrexate: an effective combination therapy for recalcitrant pemphigus vulgaris

94 combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model

95 a novel temperature-responsive micelle for enhancing combination therapy

96 results of original herbal medicinal product use in combination therapy of pyelonephritis in children

97 combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake

98 glp-1 based combination therapy for obesity and diabetes

99 case report: combination therapy with mesenchymal stem cells and granulocyte-colony stimulating factor in a case of spinal cord injury

100 valsartan combination therapy in the management of hypertension &ndash; patient perspectives and clinical utility

101 comparison of health service utilization for febrile children before and after introduction of malaria rapid diagnostic tests and artemisinin-based combination therapy in rural papua new guinea

Keyword Connections

Journals

Research Groups

Bibliographies